Gyrodyne Llc Financials
This page shows Gyrodyne Llc (GYRO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Gyrodyne’s visible story is a shrinking balance sheet: assets fell, but equity absorbed most of the drop.
From the 2015 year-end balance sheet to the latest 2016 balance sheet, liabilities fell by$3.6M while equity fell by$13.6M , so the contraction was not mainly debt reduction. That is why debt-to-equity rose to 0.4x from 0.3x even though liabilities declined to$10.9M .
The last period with operating data, 2014, showed only
Some figures from recent filings were inconsistent and were omitted from this summary.
Financial Health Signals
Based on FY2016 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Gyrodyne Llc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Gyrodyne Llc carries a low D/E ratio of 0.36, meaning only $0.36 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 95/100, indicating a strong balance sheet with room for future borrowing.
Key Financial Metrics
Earnings & Revenue
Cash & Balance Sheet
Gyrodyne Llc held $4.3M in cash against $0 in long-term debt as of fiscal year 2016.
Gyrodyne Llc had 1M shares outstanding in fiscal year 2016. This represents an increase of 0.0% from the prior year.
Margins & Returns
Capital Allocation
GYRO Income Statement
| Metric | Q3'26 | Q2'26 | Q2'25 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | $425K | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | $458K | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | $149K | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | $15K | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | -$891K | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GYRO Balance Sheet
| Metric | Q3'26 | Q2'26 | Q2'25 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $58.1M-1.0% | $58.7M+3.6% | $56.7M+38.7% | $40.9M-28.4% | $57.1M-1.4% | $57.9M+3.2% | $56.1M+27.8% | $43.9M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $4.0M-12.8% | $4.5M-23.2% | $5.9M+36.5% | $4.3M-30.2% | $6.2M+5.3% | $5.9M-22.9% | $7.6M+89.1% | $4.0M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $151K-2.7% | $155K-53.8% | $336K | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $32.2M-2.0% | $32.8M+26.0% | $26.1M+139.8% | $10.9M-19.6% | $13.5M-6.4% | $14.4M+47.7% | $9.8M-52.1% | $20.4M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $10.8M-0.7% | $10.9M-2.7% | $11.2M | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $25.9M+0.3% | $25.9M-15.5% | $30.6M+2.0% | $30.0M-31.2% | $43.6M+0.3% | $43.5M-1.1% | $43.9M+87.2% | $23.5M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$12.9M |
GYRO Cash Flow Statement
| Metric | Q3'26 | Q2'26 | Q2'25 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$305K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$44K |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GYRO Financial Ratios
| Metric | Q3'26 | Q2'26 | Q2'25 | Q4'16 | Q3'16 | Q2'16 | Q1'16 | Q2'15 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | -209.7% | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | -2.0% | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | -1.6% | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.420.0 | 0.42+0.1 | 0.370.0 | 0.36+0.1 | 0.31-0.0 | 0.33+0.1 | 0.22-0.6 | 0.87 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What are Gyrodyne Llc's total assets?
Gyrodyne Llc (GYRO) had $40.9M in total assets as of fiscal year 2016, including both current and long-term assets.
What is Gyrodyne Llc's debt-to-equity ratio?
Gyrodyne Llc (GYRO) had a debt-to-equity ratio of 0.36 as of fiscal year 2016, measuring the company's financial leverage by comparing total debt to shareholder equity.
How financially healthy is Gyrodyne Llc?
Gyrodyne Llc (GYRO) scores 16 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.